WebBased on the work of Professor Jim Huntington (Cambridge Institute for Medical Research) and Dr Trevor Baglin (Cambridge University Hospitals), Apcintex has developed a new treatment that seeks to turn down the activity of a key natural anticoagulant pathway to produce normal blood clotting in patients with haemophilia. WebJim Huntington has 4 current jobs including Founder, CEO, Scientific Advisor and Director at Z Factor, CEO at ApcinteX, and Founder/Director at Cambridge Protein Works. …
@JHuntingtonUCam Twitter
WebProfessor Jim Huntington Professor Brian Huntly Dr Elisa Laurenti Professor Simón Méndez-Ferrer Dr Jyoti Nangalia Professor Willem H Ouwehand Professor Randy J Read Dr Ingo Ringshausen Professor Nicole Soranzo Dr Konstantinos Tzelepis Professor George Vassiliou Professor Alan J Warren WebCambridge Enterprise played a crucial role in all steps of the development of ichorcumab - from patenting to licensing to the final negotiation to get this taken over by a big pharma. … rakuten s21
Professor James Huntington The Academy of Medical Sciences
Web21 feb. 2024 · Cambridge Blood and Stem Cell Biobank NIHR BioResource Staff Principal Investigators Equality, Diversity & Wellbeing Vacancies Students MPhil PhD Events Cambridge Cancer Epigenetics Club Contact Us Dr Ingo Ringshausen CRUK Senior Clinical Research Fellow Email: [email protected] Home page: … Web14 dec. 2024 · Key Publications. Sturgess KH, Wilson NK, Gottgens B. “Single Cell Genomics – a new chapter in how technological advances propel Hemato-Oncology” Blood. 2024 Sep 14:blood.2024024361. Wehling A, Loeffler D, Zhang Y, Kull T, Donato C, Szczerba BM, Camargo Ortega G, Lee M, Moor A, Gottgens B, Aceto N, Schroeder T. … WebProfessor Jim Huntington, FMedSci Cambridge Institute for Medical Research About us Research & Facilities People Studying & Working Public Engagement Intranet (CIMR … rakuten s21 ultra 5g